Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-9q27g Total loading time: 0 Render date: 2024-07-17T18:18:27.505Z Has data issue: false hasContentIssue false

11 - Neuropeptides I: classification, synthesis and co-localization with classical neurotransmitters

Published online by Cambridge University Press:  05 June 2015

Michael Wilkinson  and
Richard E. Brown
Michael Wilkinson
Affiliation:
Dalhousie University, Nova Scotia
Richard E. Brown
Affiliation:
Dalhousie University, Nova Scotia
Get access

Summary

Many chemical messengers regulate neural activity, including neurotransmitters (Chapter 5), steroid hormones (Chapter 9) and peptide hormones (Chapter 10). This chapter, and Chapter 12, examines how the class of chemical messengers termed neuropeptides regulates neural activity. The topic of neuropeptides is now an extensive one and we divide the coverage into two parts. This chapter will describe the classification and synthesis of neuropeptides and their co-localization with classical neurotransmitters. Chapter 12 examines the functions of neuropeptides in the brain and neuroendocrine system.

Classification of neuropeptides

The realization that neuropeptides can act as neurotransmitters took place after the discovery of most of the “classical,” or small molecule, neurotransmitters, such as NE, glutamate and ACh. Perhaps the simplest and obvious difference between these two classes of neurotransmitter is the size of the molecules; neuropeptides range in size from 2 to at least 40 amino acids, whereas a molecule such as NE is derived from a single amino acid (tyrosine) (see Table 7.1). Another difference is that neuropeptides are more versatile in their range of biological activities. For example, some peptide hormones are synthesized in endocrine glands, in fat cells and in the GI tract, but are also produced in the brain, where they act as neurotransmitters or neuromodulators. Another significant distinguishing characteristic of neuropeptides is their mode of synthesis. Classical neurotransmitters such as amino acids or catecholamines are formed by two or three enzymatic steps, often in the nerve terminal. Neuropeptides, on the other hand, are synthesized from large prepropeptides in the neuronal cell body (e.g. see section 7.2.1; Figure 7.2).

In terms of nomenclature, peptide hormones were traditionally and sensibly named after the first function they were known to serve. Thus, the pituitary hormones (ACTH, TSH, FSH, GH, etc.) were named for their actions at their target cells; for example, TSH stimulates the thyroid gland. Hypothalamic-releasing hormones (CRH, TRH, GnRH, GHRH, etc.) were named for their functions at pituitary target cells; and the hormones of the gastrointestinal (GI) tract (CCK, VIP, gastrin, etc.) were named based on their gastrointestinal functions.

Type
Chapter
Information
An Introduction to Neuroendocrinology , pp. 257 - 285
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abbott, N. J., Ronnback, L. and Hansson, E. (2006). “Astrocyte-endothelial interactions at the blood-brain barrier,” Nat Rev Neurosci 7, 41–53.CrossRefGoogle ScholarPubMed
Acher, R. (1993). “Neurohypophysial peptide systems: processing machinery, hydroosmotic regulation, adaptation and evolution,” Regul Pept 45, 1–13.CrossRefGoogle ScholarPubMed
Appetecchia, M. and Baldelli, R. (2010). “Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives,” J Exp Clin Cancer Res 29, 19.CrossRefGoogle ScholarPubMed
Baldwin, G. S., Patel, O. and Shulkes, A. (2010). “Evolution of gastrointestinal hormones: the cholecystokinin/gastrin family,” Curr Opin Endocrinol Diabetes Obes 17, 77–88.CrossRefGoogle ScholarPubMed
Begley, D. J. (2004). “Delivery of therapeutic agents to the central nervous system: the problems and the possibilities,” Pharmacol Ther 104, 29–45.CrossRefGoogle ScholarPubMed
Boron, W. F. and Boulpaep, E. L. (2005). Medical Physiology, updated edn. (Philadelphia, PA: Elsevier Saunders).Google Scholar
Bos, P. A., Panksepp, J., Bluthe, R. M. and Honk, J. V. (2012). “Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: a review of single administration studies,” Front Neuroendocr 33, 17–35.CrossRefGoogle ScholarPubMed
Burnstock, G. (1976). “Do some nerve cells release more than one transmitter?”Neurosci 1, 239–248.CrossRefGoogle Scholar
Burnstock, G. (2004). “Cotransmission,” Curr Opin Pharmacol 4, 47–52.CrossRefGoogle ScholarPubMed
Choleris, E., Devidze, N., Kavaliers, M. and Pfaff, D. W. (2008). “Steroidal/neuropeptide interactions in hypothalamus and amygdala related to social anxiety,” Prog Brain Res 170, 291–303.Google ScholarPubMed
Coleman, P. J. and Renger, J. J. (2010). “Orexin receptor antagonists: a review of promising compounds patented since 2006,” Expert Opin Ther Pat 20, 307–324.CrossRefGoogle ScholarPubMed
Corbett, A. D., Henderson, G., McKnight, A. T. and Paterson, S. J. (2006). “75 years of opioid research: the exciting but vain quest for the Holy Grail,” Br J Pharmacol 147(Suppl. 1), S153–S162.Google ScholarPubMed
Crane, J. F. and Trainor, P. A. (2006). “Neural crest stem and progenitor cells,” Annu Rev Cell Dev Biol 22, 267–286.CrossRefGoogle ScholarPubMed
Cruz-Gordillo, P., Fedrigo, O., Wray, G. A. and Babbitt, C. C. (2010). “Extensive changes in the expression of the opioid genes between humans and chimpanzees,” Brain Behav Evol 76, 154–162.CrossRefGoogle ScholarPubMed
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W. and Kelley, K. W. (2008). “From inflammation to sickness and depression: when the immune system subjugates the brain,” Nat Rev Neurosci 9, 46–56.CrossRefGoogle Scholar
Darlison, M. G. and Richter, D. (1999). “Multiple genes for neuropeptides and their receptors: co-evolution and physiology,” Trends Neurosci 22, 81–88.CrossRefGoogle ScholarPubMed
Day, R. and Salzet, M. (2002). “The neuroendocrine phenotype, cellular plasticity, and the search for genetic switches: redefining the diffuse neuroendocrine system,” Neuro Endocrinol Lett 23, 447–451.Google ScholarPubMed
De Vries, , , G. J. and Panzica, G. C. (2006). “Sexual differentiation of central vasopressin and vasotocin systems in vertebrates: different mechanisms, similar endpoints,” Neurosci 138, 947–955.CrossRefGoogle ScholarPubMed
Decaux, G., Soupart, A. and Vassart, G. (2008). “Non-peptide arginine-vasopressin antagonists: the vaptans,” Lancet 371, 1624–1632.CrossRefGoogle ScholarPubMed
Di Fabio, R., Alvaro, G., Griffante, C., Pizzi, D. A., Donati, D., Mattioli, M.et al. (2011). “Discovery and biological characterization of (2R,4 S)-1'-acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fl uoro-2-methylphenyl)-N-methyl-4,4'-bipiperidine-1-carboxamide as a new potent and selective neurokinin 1 (NK1) receptor antagonist clinical candidate,” J Med Chem 54, 1071–1079.CrossRefGoogle Scholar
Dimaline, R. and Dockray, G. J. (1994). “Evolution of the gastrointestinal endocrine system (with special reference to gastrin and CCK),” Baillieres Clin Endocrinol Metab 8, 1–24.CrossRefGoogle Scholar
Douglas, A. J. and Russell, J. A. (2001). “Endogenous opioid regulation of oxytocin and ACTH secretion during pregnancy and parturition,” Prog Brain Res 133, 67–82.Google ScholarPubMed
El Mestikawy, S., Wallen-Mackenzie, A., Fortin, G. M., Descarries, L. and Trudeau, L. E. (2011). “From glutamate co-release to vesicular synergy: vesicular glutamate transporters,” Nat Rev Neurosci 12, 204–216.Google ScholarPubMed
End, K., Gamel-Didelon, K., Jung, H., Tolnay, M., Ludecke, D., Gratzl, M.et al. (2005). “Receptors and sites of synthesis and storage of gamma-aminobutyric acid in human pituitary glands and in growth hormone adenomas,” Am J Clin Pathol 124, 550–558.CrossRefGoogle ScholarPubMed
Engel, J. B. and Schally, A. V. (2007). “Drug insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone,” Nat Clin Pract Endocrinol Metab 3, 157–167.CrossRefGoogle ScholarPubMed
Fields, J. D. and Bhardwaj, A. (2009). “Non-peptide arginine-vasopressin antagonists (vaptans) for the treatment of hyponatremia in neurocritical care: a new alternative?”Neurocrit Care 11, 1–4.CrossRefGoogle Scholar
Fraser, M., Matthews, S. G., Braems, G., Jeffray, T. and Challis, J. R. (1997). “Developmental regulation of preproenkephalin (PENK) gene expression in the adrenal gland of the ovine fetus and newborn lamb: effects of hypoxemia and exogenous cortisol infusion,” J Endocrinol 155, 143–149.CrossRefGoogle ScholarPubMed
Häussler, H. U., Jirikowski, G. F. and Caldwell, J. D. (1990). “Sex differences among oxytocin-immunoreactive neuronal systems in the mouse hypothalamus,” J Chem Neuroanat 3, 271–276.Google ScholarPubMed
Heaney, A. P. and Melmed, S. (2004). “Molecular targets in pituitary tumours,” Nat Rev Cancer 4, 285–295.CrossRefGoogle ScholarPubMed
Henion, P. D. and Landis, S. C. (1992). “Developmental regulation of leucine-enkephalin expression in adrenal chromaffin cells by glucocorticoids and innervation,” J Neurosci 12, 3818–3827.CrossRefGoogle ScholarPubMed
Hokfelt, T., Johansson, O., Ljungdahl, A., Lundberg, J. M. and Schultzberg, M. (1980). “Peptidergic neurones,” Nature 284, 515–521.CrossRefGoogle ScholarPubMed
Houben, H. and Denef, C. (1990). “Regulatory peptides produced in the anterior pituitary,” Trends Endocrinol Metab 1, 398–403.CrossRefGoogle ScholarPubMed
Hrabovszky, E., Deli, L., Turi, G. F., Kallo, I. and Liposits, Z. (2007). “Glutamatergic innervation of the hypothalamic median eminence and posterior pituitary of the rat,” Neurosci 144, 1383–1392.CrossRefGoogle ScholarPubMed
Hrabovszky, E., Kallo, I., Turi, G. F., May, K., Wittmann, G., Fekete, C.et al. (2006). “Expression of vesicular glutamate transporter-2 in gonadotrope and thyrotrope cells of the rat pituitary. Regulation by estrogen and thyroid hormone status,” Endocr 147, 3818–3825.CrossRefGoogle ScholarPubMed
Hrabovszky, E. and Liposits, Z. (2008). “Novel aspects of glutamatergic signalling in the neuroendocrine system,” J Neuroendocrinol 20, 743–751.CrossRefGoogle ScholarPubMed
Imura, H., Kato, Y., Nakai, Y., Nakao, K., Tanaka, I., Jingami, H.et al. (1985). “Endogenous opioids and related peptides: from molecular biology to clinical medicine. The Sir Henry Dale lecture for 1985,” J Endocrinol 107, 147–157.CrossRefGoogle Scholar
Julius, D. (1997). “Another opiate for the masses?”Nature 386, 442.CrossRefGoogle Scholar
Kastin, A. J. and Pan, W. (2010). “Concepts for biologically active peptides,” Curr Pharm Des 16, 3390–3400.CrossRefGoogle ScholarPubMed
Kauffman, A. S. (2010). “Gonadal and nongonadal regulation of sex differences in hypothalamic Kiss1 neurones,” J Neuroendocrinol 22, 682–691.Google ScholarPubMed
Kim, H., Toyofuku, Y., Lynn, F. C., Chak, E., Uchida, T., Mizukami, H.et al. (2010). “Serotonin regulates pancreatic beta cell mass during pregnancy,” Nat Med 16, 804–808.CrossRefGoogle ScholarPubMed
Kocsis, Z. S., Molnar, C. S., Watanabe, M., Daneels, G., Moechars, D., Liposits, Z.et al. (2010). “Demonstration of vesicular glutamate transporter-1 in corticotroph cells in the anterior pituitary of the rat,” Neurochem Int 56, 479–486.CrossRefGoogle ScholarPubMed
Krieger, D. T. (1984). “Brain peptides,” Vitam Horm 41, 1–50, 275–281.Google ScholarPubMed
Krolewski, D. M., Medina, A., Kerman, I. A., Bernard, R., Burke, S., Thompson, R. C.et al. (2010). “Expression patterns of corticotropin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypothalamus,” J Comp Neurol 518, 4591–4611.CrossRefGoogle ScholarPubMed
Kupfermann, I. (1991). “Functional studies of cotransmission,” Physiol Rev 71, 683–732.CrossRefGoogle ScholarPubMed
Landry, M., Roche, D., Angelova, E. and Calas, A. (1997). “Expression of galanin in hypothalamic magnocellular neurones of lactating rats: co-existence with vasopressin and oxytocin,” J Endocrinol 155, 467–481.CrossRefGoogle ScholarPubMed
Largent-Milnes, T. M. and Vanderah, T. W. (2010). “Recently patented and promising ORL-1 ligands: where have we been and where are we going?”Expert Opin Ther Pat 20, 291–305.CrossRefGoogle Scholar
Le Roith, D., Shiloach, J. and Roth, J. (1982). “Is there an earlier phylogenetic precursor that is common to both the nervous and endocrine systems?”Peptides 3, 211–215.CrossRefGoogle Scholar
Le Roith, D., Delahunty, G., Wilson, G. L., Roberts, C. T. Jr., Shemer, J., Hart, C.et al. (1986). “Evolutionary aspects of the endocrine and nervous systems,” Recent Prog Horm Res 42, 549–587.Google Scholar
Liposits, Z., Reid, J. J., Negro-Vilar, A. and Merchenthaler, I. (1995). “Sexual dimorphism in copackaging of luteinizing hormone-releasing hormone and galanin into neurosecretory vesicles of hypophysiotrophic neurons: estrogen dependency,” Endocr 136, 1987–1992.CrossRefGoogle ScholarPubMed
Llona, I., Annaert, W. G., Jacob, W. and De Potter, W. P. (1994). “Co-storage in large ‘dense-core’ vesicles of dopamine and cholecystokinin in rat striatum,” Neurochem Int 25, 573–581.CrossRefGoogle ScholarPubMed
Lowery, E. G. and Thiele, T. E. (2010). “Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism,” CNS Neurol Disord Drug Targets 9, 77–86.CrossRefGoogle ScholarPubMed
Ludwig, M. and Leng, G. (2006). “Dendritic peptide release and peptide-dependent behaviours,” Nat Rev Neurosci 7, 126–136.CrossRefGoogle ScholarPubMed
Manjila, S., Wu, O. C., Khan, F. R., Khan, M. M., Arafah, B. M. and Selman, W. R. (2010). “Pharmacological management of acromegaly: a current perspective,” Neurosurg Focus 29, E14.CrossRefGoogle ScholarPubMed
Mansour, A., Fox, C. A., Akil, H. and Watson, S. J. (1995b). “Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications,” Trends Neurosci 18, 22–29.CrossRefGoogle ScholarPubMed
Meister, B., Cortes, R., Villar, M. J., Schalling, M. and Hokfelt, T. (1990). “Peptides and transmitter enzymes in hypothalamic magnocellular neurons after administration of hyperosmotic stimuli: comparison between messenger RNA and peptide/protein levels,” Cell Tissue Res 260, 279–297.CrossRefGoogle ScholarPubMed
Meister, B. and Hokfelt, T. (1988). “Peptide- and transmitter-containing neurons in the mediobasal hypothalamus and their relation to GABAergic systems: possible roles in control of prolactin and growth hormone secretion,” Synapse 2, 585–605.CrossRefGoogle ScholarPubMed
Merchenthaler, I. (1991). “Current status of brain hypophysiotropic factors: morphologic aspects,” Trends Endocrinol Metab 2, 219–226.CrossRefGoogle ScholarPubMed
Minakata, H. (2010). “Oxytocin/vasopressin and gonadotropin-releasing hormone from cephalopods to vertebrates,” Ann NY Acad Sci 1200, 33–42.CrossRefGoogle ScholarPubMed
Moalic, J. M., Le Strat, Y., Lepagnol-Bestel, A. M., Ramoz, N., Loe-Mie, Y., Maussion, G.et al. (2010). “Primate-accelerated evolutionary genes: novel routes to drug discovery in psychiatric disorders,” Curr Med Chem 17, 1300–1316.CrossRefGoogle ScholarPubMed
Mohr, E., Meyerhof, W. and Richter, D. (1995). “Vasopressin and oxytocin: molecular biology and evolution of the peptide hormones and their receptors,” Vitam Horm 51, 235–266.Google ScholarPubMed
Mollereau, C. and Mouledous, L. (2000). “Tissue distribution of the opioid receptor-like (ORL1) receptor,” Peptides 21, 907–917.CrossRefGoogle ScholarPubMed
Nestler, E. J., Hyman, S. E. and Malenka, R. C. (2009). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience, nd edn. (New York: McGraw Hill).Google Scholar
Nieuwenhuys, R. (1985). Chemoarchitecture of the Brain (Berlin: Springer Verlag).CrossRefGoogle Scholar
Nusbaum, M. P., Blitz, D. M., Swensen, A. M., Wood, D. and Marder, E. (2001). “The roles of co-transmission in neural network modulation,” Trends Neurosci 24, 146–154.CrossRefGoogle ScholarPubMed
Osborne, N. N. (1981). “Communication between neurones: current concepts,” Neurochem Int 3, 3–16.CrossRefGoogle ScholarPubMed
Reyes, R., Valladares, F., Diaz-Flores, L., Feria, L., Alonso, R., Tramu, G.et al. (2007). “Immunohistochemical localization of hormones and peptides in the human pituitary cells in a case of hypercortisolism by ACTH secreting microadenoma,” Histol Histopathol 22, 709–717.Google Scholar
Ribeiro-da-Silva, A. and Hokfelt, T. (2000). “Neuroanatomical localisation of Substance P in the CNS and sensory neurons,” Neuropeptides 34, 256–271.CrossRefGoogle ScholarPubMed
Roch, G. J., Busby, E. R. and Sherwood, N. M. (2011). “Evolution of GnRH: diving deeper,” Gen Comp Endocrinol 171, 1–16.CrossRefGoogle ScholarPubMed
Roth, J., Le Roith, D., Collier, E. S., Weaver, N. R., Watkinson, A., Cleland, C. F.et al. (1985). “Evolutionary origins of neuropeptides, hormones and receptors: possible applications to immunology,” J Immunol 135, 816s–819s.Google ScholarPubMed
Roth, J., Le Roith, D., Lesniak, M. A., de Pablo, F., Bassas, L. and Collier, E. (1986). “Molecules of intercellular communication in vertebrates, invertebrates and microbes: do they share common origins?”Prog Brain Res 68, 71–79.Google Scholar
Russo, A. F., Clark, M. S. and Durham, P. L. (1996). “Thyroid parafollicular cells. An accessible model for the study of serotonergic neurons,” Mol Neurobiol 13, 257–276.Google Scholar
Sato, N., Ogino, Y., Mashiko, S. and Ando, M. (2009). “Modulation of neuropeptide Y receptors for the treatment of obesity,” Expert Opin Ther Pat 19, 1401–1415.CrossRefGoogle ScholarPubMed
Semaan, S. J. and Kauffman, A. S. (2010). “Sexual differentiation and development of forebrain reproductive circuits,” Curr Opin Neurobiol 20, 424–431.CrossRefGoogle ScholarPubMed
Stewart, J. M. and Channabasavaiah, K. (1979). “Evolutionary aspects of some neuropeptides,” Fed Proc 38, 2302–2308.Google ScholarPubMed
Tauchi, M., Zhang, R., D'Alessio, D. A., Stern, J. E. and Herman, J. P. (2008). “Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei,” J Chem Neuroanat 36, 144–149.CrossRefGoogle ScholarPubMed
Telleria-Diaz, A., Grinevich, V. V. and Jirikowski, G. F. (2001). “Co-localization of vasopressin and oxytocin in hypothalamic magnocellular neurons in water-deprived rats,” Neuropeptides 35, 162–167.CrossRefGoogle Scholar
Toni, R. (2004). “The neuroendocrine system: organization and homeostatic role,” J Endocrinol Invest 27, 35–47.Google ScholarPubMed
Torrealba, F. and Carrasco, M. A. (2004). “A review on electron microscopy and neurotransmitter systems,” Brain Res Rev 47, 5–17.CrossRefGoogle ScholarPubMed
Trudeau, L. E. and Gutierrez, R. (2007). “On cotransmission and neurotransmitter phenotype plasticity,” Mol Interv 7, 138–146.CrossRefGoogle ScholarPubMed
Unsicker, K. (1993). “The trophic cocktail made by adrenal chromaffin cells,” Exp Neurol 123, 167–173.CrossRefGoogle ScholarPubMed
Viero, C., Shibuya, I., Kitamura, N., Verkhratsky, A., Fujihara, H., Katoh, A.et al. (2010). “REVIEW: Oxytocin: crossing the bridge between basic science and pharmacotherapy,” CNS Neurosci Ther 16, e138–e156.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×